Copyright © 1999 by the European Society of Cardiology.
Perspective
Improving outcome in acute coronary syndromes as good as it gets?
Clinical European Studies in Angina and Revascularization (CESAR) Trials Unit, Royal Brompton & Harefield NHS Trust, London, U.K.
References
- Graves, EJ, National hospital discharge survey: annual summary, 1991, 1993
- N Engl J Med. 1996;335:775782
[Abstract/Free Full Text] - Lewis HD Jr, Davis JW, Archibald DG. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med. 1983;309:396403[Abstract]
- Rizik D, Timmis GC, Grines CL, Bakalyar D, Schreiber T. Immediate use of beta blockers, but not calcium blockers, improves prognosis in unstable angina (Abstr). Circulation. 1991;84:II345
- Eur Heart J. 1986;56:400413
- Patel DJ, Purcell HJ, Fox KM. Cardioprotection by opening of the KATPchannel in unstable angina. Eur Heart J. 1999;20:5157
[Abstract/Free Full Text] - Patel DJ, Knight CJ, Holdright DR. Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST segment monitoring. Eur Heart J. 1998;19:240249
[Abstract/Free Full Text] - Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation. 1997;96:25782585
[Abstract/Free Full Text] - Lindahl B, Andren B, Ohisson J, Venge P, Wallentin L. Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. Eur Heart J. 1997;18:762770
[Abstract/Free Full Text] - Boden WE, O'Rourke RA, Crawford MH. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med. 1998;338:17851792
[Abstract/Free Full Text] - Yusuf S, Flather M, Pogue J. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet. 1998;352:507514[CrossRef][Web of Science][Medline]
- Halon DA, Flugelman MY, Merdler A, Rennert H, Shahla J, Lewis BS. Long-term (10 year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty. J Am Coll Cardiol. 1998;32:16031609
[Abstract/Free Full Text] - Cannon CP, Weintraub WS, Demopoulos, Robertson DH, Gormley GJ, Braunwald E. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 trial. Am J Cardiol. 1998;82:731736[CrossRef][Web of Science][Medline]
- Lancet. 1999;354:708715[CrossRef][Web of Science][Medline]
- Circulation. 1994;89:15451556
[Abstract/Free Full Text] - Br J Cardiol. 1999;6:192196
- Ridker PM, Rifai N, Pfeffer MA. Inflammation, pravastatin, and risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 1998;98:839844
[Abstract/Free Full Text] - Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomized trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS a pilot study. Lancet. 1997;350:404407[CrossRef][Web of Science][Medline]
- Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS study. Eur Heart J. 1999;20:121127
[Abstract/Free Full Text] - Anand SS, Yusuf S, Pogue J, Weitz JI, Flather M. Long-term oral anticoagulation therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction. Circulation. 1998;98:10641070
[Abstract/Free Full Text] - Purcell H, Fox KM. Current roles and future possibilities for low-molecular-weight heparins in unstable angina. Eur Heart J. 1998;19:K18K23
- Lancet. 1996;347:561568[CrossRef][Web of Science][Medline]
- Klein W, Buchwald A, Hillis SE. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in Unstable Coronary Artery Disease Study (FRIC). Circulation. 1997;96:6168
[Abstract/Free Full Text] - Lancet. 1999;354:701707[CrossRef][Web of Science][Medline]
- Cohen M, Demers C, Gurfinkel EP. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med. 1997;337:447452
[Abstract/Free Full Text] - Cohen M, Bigonzi F, Le Louer V, Gosset F, Fromell GJ, Goodman S. One year follow-up of the ESSENCE Trial (enoxaparin versus heparin in unstable angina and Non-Q-Wave myocardial infarction). J Am Coll Cardiol. 1998;31:79A
- Verheught FWA. Hotline sessions at the 20th European Congress of Cardiology. Eur Heart J. 1998;20:710
- Eur Heart J. 1999;20:15531562
[Abstract/Free Full Text] - Montalescot G, Philippe F, Ankri A. Early increase in von Willebrand factor predicts adverse outcome in unstable coronary artery disease. Beneficial effects of enoxaparin. Circulation. 1998;98:294299
[Abstract/Free Full Text] - Lancet. 1999;353:429438[CrossRef][Web of Science][Medline]
- Braunwald E, Maseri A, Armstrong PW. Rationale and clinical evidence for use of GP IIb/IIIa inhibitors in acute coronary syndromes. Am Heart J. 1998;135:S56S66[CrossRef][Web of Science][Medline]
- Lancet. 1997;349:14291435[CrossRef][Web of Science][Medline]
- Ronner E, Dykun Y, van den Brand MJBM, van der Wieken LR, Simoons ML. Platelet glycoprotein IIb/IIIa receptor antagonists. Eur Heart J. 1998;19:16081616
[Free Full Text] - Wilcox, R, Presentation, 1999
- Hughes S. Speculation rife on orbofiban mortality. Scrip. 1998;22:
- Goy J-J. Contemporary approach to management of unstable angina. Lancet. 1999;354:694695[CrossRef][Web of Science][Medline]
- Clinical practice guideline-unstable angina: diagnosis and management
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||